Dr. Thomas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pulmonary Disease and Critical Care Medicine, 1995 - 1998
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1992 - 1995
- University of Texas Medical Branch School of MedicineClass of 1992
- University of Texas at AustinB.A., Zoology, 1984 - 1988
Certifications & Licensure
- MN State Medical License 1993 - 2025
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Outstanding Educator, Internal Medicine Residency Program Mayo Clinic, 2008-2010
- Outstanding Educator, Mayo Medical School Mayo Clinic, 2003
- Burgher Family Fellowship Award in Pulmonary Diseases Mayo Clinic, 1998
- Join now to see all
Clinical Trials
- Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients Non-Small Lung Cancer Start of enrollment: 2012 May 01
Publications & Presentations
PubMed
- 3 citationsDIPNECH: pragmatic approach, uncertainties, notable associations, and a proposal for an improved definition.Bilal F Samhouri, Thorvardur R Halfdanarson, Chi Wan Koo, Cormac McCarthy, Eunhee S Yi
Endocrine-Related Cancer. 2023-10-01 - 42 citationsPathways impacted by genomic alterations in pulmonary carcinoid tumorsMichael K. Asiedu, Charles F. Thomas, Jie Dong, Sandra C. Schulte, Prasidda Khadka
Clinical Cancer Research. 2018-04-01 - 26 citationsManagement of Multifocal Lung Cancer: Results of a SurveyKonstantinos Leventakos, Tobias Peikert, David E. Midthun, Julian R. Molina, Shanda H. Blackmon
Journal of Thoracic Oncology. 2017-09-01
Journal Articles
- The IASLC Lung Cancer Staging Project Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung CancerRamón Rami-Porta, MD, FETCS,* Vanessa Bolejack, MPH,† John Crowley, PhD,† David Ball, MD, FRANZCR,‡ Jhingook Kim, MD,§ Gustavo Lyons, MD,║ Thomas Rice, MD,¶ Kenji Suzu..., Journal of Thoracic Oncology, 7/2015
- The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposal for an Evidence-Based Stage Classification System for the Forthcoming (8th) Edition of the TNM Class...Detterbeck Frank C, Stratton Kelly, Giroux Dorothy, Asamura Hisao, Crowley John, Falkson Conrad, Filosso Pier Luigi, Frazier Aletta A, Giaccone Giuseppe, Huang James, ..., Journal of Thoracic Oncology. September 2014; 9(9):s65-72, 9/2014
- The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the T component for the Forthcoming (8th) Edition of the TNM Classification of Malignant TumorsNicholson Andrew G, Detterbeck Frank C, Marino Mirella, Kim Jhingook, Stratton Kelly MS‖, Giroux Dorothy, Asamura Hisao, Crowley John, Falkson Conrad, Filosso Pier Lui..., Journal of Thoracic Oncology. September 2014; 9(9):s73-80., 9/2014
- Join now to see all
Other
- Epidemiology, clinical manifestations, and diagnosis of Pneumocystis pneumonia in non-HIV-infected patientsThomas CF, Limper AH
http://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-pneumocystis-
UpToDate, Wolters Kluwer Health - 2013-02-27 - Treatment and prevention of Pneumocystis pneumonia in non-HIV-infected patientsThomas CF, Limper AH
http://www.uptodate.com/contents/treatment-and-prevention-of-pneumocystis-pneumonia-in-non-hiv-infec
UpToDate, Wolters Kluwer Health - 2013-02-27 - Bronchial carcinoid tumors: Epidemiology, risk factors, classification, histology, diagnosis, and stagingThomas CF, Jett JR
http://www.uptodate.com/contents/bronchial-carcinoid-tumors-epidemiology-risk-factors-classification
UpToDate, Wolters Kluwer Health - 2012-08-30 - Join now to see all
Grant Support
- Pheromone Signaling in Pneumocystis cariniiNational Institutes of Health2005–2010
- Control of the Pneumocystis Cell Cycle - Co-investigatorNational Institutes of Health2004–2009
- Altered Growth Factor Signaling in Pulmonary Carcinoid TumorsMayo Foundation for Education and Research2007–2008
- Respiratory Biology Research Training Grant - Faculty memberNational Institutes of Health1998–2008
- A Double-Blind, Parallel, Placebo-Controlled, Randomized Study of the Efficacy and Safety of Etanercept in Patients with Idiopathic Pulmonary FibrosisWyeth-Ayerst Research2002–2006
- An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon Gamma-1b (INF-1b) in Patients with Idiopathic Pulmonary Fibrosis (GIPF-004).INTERMUNE2002–2005
- Pheromone Signaling In Pneumocystis cariniiNational Institutes of Health2002–2005
- Pheromone Signal Transduction in Pneumocystis cariniiMayo Foundation for Education and Research2001–2003
- Life Cycle Regulation of Pneumocystis carinii by MAPKNational Institutes of Health1998–2001
- Identification of the Pneumocystis carinii cdc2 HomologueGlaxo Wellcome Pulmonary Fellowship Award Program1996–1997
Committees
- Member of the Staging Committee, International Association for the Study of Lung Cancer 2010 - Present
- Ad Hoc Program Committee Reviewer, European Respiratory Society, Respiratory Infections Section 2000 - Present
- Grant Reviewer, LUNGevity Foundation Study Section for LUNGevity Lung Cancer Early Detection Award and LUNGevity Lung Cancer Targeted Therapeutics Award 2011 - 2011
- Grant Reviewer, French National Research Agency (l'Agence Nationale de la Recherche (ANR) 2010 - 2010
- Chair, Nominating Committee , Assembly on Microbiology, Tuberculosis, and Pulmonary Infections (MTPI), American Thoracic Society 2008 - 2009
- Grant Reviewer, NIH/NHLBI Study Section for Program Project Grant “Lung Damage from P. carinii: Pathogenesis and Prevention”, HLBP S Workgroup 020 2007 - 2007
- Nominating Committee Member, Assembly on Microbiology, Tuberculosis, and Pulmonary Infections (MTPI), American Thoracic Society 2006 - 2009
- Grant Reviewer, NIH/NIAID Study Section for AIDS Fellowship Applications Special Emphasis Panel/Scientific Review Group 2007/01 ZRG1 AARR-D (22) 2006 - 2006
- Grants Reviewer, Swiss National Science Foundation FNSNF 2006 - 2006
- Review group member, Cochrane Collaborative Review Group, “Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients 2005 - 2005
- Grant Reviewer, NIH/NHLBI Study Section for “Infectious Agents in the Origins of Chronic Lung Disease ZHL1 CSR-H (F1)” 2005 - 2005
- Grants Reviewer, Swiss National Science Foundation FNSNF 2004 - 2004
- Grant reviewer, Veterans Affairs Merit Review Grants 2003 - 2003
- Chair, Midwest Section of the American Federation for Medical Research, American Federation for Medical Research 2001 - 2002
- Chair-Elect, Midwest Section of the American Federation for Medical Research, American Federation for Medical Research 2000 - 2001
- Program Committee Member, Assembly on Microbiology, Tuberculosis, and Pulmonary Infections (MTPI), American Thoracic Society 1999 - 2004
- Councilor, American Federation for Medical Research 1998 - 2000
Professional Memberships
- Member
- Member
- International Association for the Study of Lung Cancer (IASLC)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: